Article
Genetic Background of Epilepsy and Antiepileptic Treatments
14 Nov 2023
Abstract excerpt
Advanced identification of the gene mutations causing epilepsy syndromes is expected to translate into faster diagnosis and more effective treatment of these conditions. Over the last 5 years, approximately 40 clinical trials on the treatment of genetic epilepsies have been conducted. As a result, some medications that are not regular antiseizure drugs (e.g., soticlestat, fenfluramine, or ganaxolone) have been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
